Ascension Health
St Louis, Missouri, 63134, United States
NCT Number: NCT06640426
Medicare Annual Wellness Visits (AWVs) are critical for addressing preventive care needs among older adults, yet the most recent estimates from the Center for Medicare Services suggest less than 50% of eligible patients take advantage of this free healthcare benefit. Behavioral science-informed messaging interventions offer a promising strategy to increase AWV participation by guiding patient behavior. In this study, investigators will evaluate a health system initiative that utilizes personalized email and text messages to encourage Medicare beneficiaries to schedule and attend their AWVs. This approach aims to boost patient engagement in preventive health services, ultimately improving care outcomes for older adult populations
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
St Louis, Missouri, 63134, United States
The Centers for Medicare & Medicaid Services (CMS) recommends Annual Wellness Visits (AWVs) to encourage preventive care and improve long-term health outcomes for Medicare beneficiaries. These visits are designed to provide a proactive approach to healthcare by focusing on identifying risk factors, updating medical histories, and developing personalized prevention plans that promote early detection of diseases. By prioritizing prevention over treatment, AWVs help reduce the overall cost burden on the healthcare system while enhancing patient engagement and empowering individuals to take a more active role in managing their health. Yet despite these benefits, most Medicare members who are eligible for an AWV - at no cost to them - do not complete one.
Behavioral science research suggests that personalized messages, designed to facilitate action, can have significant impacts on health behavior. Studies have found these messaging interventions can increase vaccination rates, cancer screening rates, and other care gap closure.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention involves receiving one personalized email and one personalized text message, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
This intervention involves patients receiving up to five personalized email and text messages, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
Time frame: 14 days
Percentage of patients who schedule an AWV
Time frame: 90 Days
Percentage of patients who have completed an AWV
Time frame: 90 days
Number of days to AWV appointment completion
Time frame: 180 days
Completion of breast cancer screening post intervention
Time frame: 180 days
Completion colon cancer screening post intervention
Time frame: 90 days
Ordering of tests for breast cancer screening
Time frame: 90 days
Ordering of tests for colon cancer screening
Laura Feemster
Industry
Messaging Intervention to Increase Medicare Annual Wellness Visits: The MIMA Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06996366
Annual Wellness Visit
Chicago, Illinois, United States
View Trial DetailsNCT04601272
Breast Cancer Screening, Colon Cancer Screening
Boston, Massachusetts, United States
View Trial DetailsNCT07592793
Behavior, Breast Cancer Screening
Boston, Massachusetts, United States
View Trial DetailsNCT07228000
Breast Cancer Screening, Colon Cancer Screening
Newark, Delaware, United States
View Trial Details